MIMI I-NAN HU to Piperidines
This is a "connection" page, showing publications MIMI I-NAN HU has written about Piperidines.
Connection Strength
0.741
-
Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer. Endocr Relat Cancer. 2019 02 01; 26(2):241-250.
Score: 0.457
-
Vandetanib photoinduced cutaneous toxicities. Cutis. 2019 May; 103(5):E24-E29.
Score: 0.116
-
Updates in the management of medullary thyroid cancer. Clin Adv Hematol Oncol. 2011 May; 9(5):391-4.
Score: 0.067
-
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study. Thyroid. 2024 01; 34(1):26-40.
Score: 0.040
-
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer. N Engl J Med. 2023 Nov 16; 389(20):1851-1861.
Score: 0.040
-
Medullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat--and with which drug--those are the questions. J Clin Endocrinol Metab. 2014 Dec; 99(12):4390-6.
Score: 0.021